Comera Life Sciences Holdings, Inc. Common Stock
CMRA
CMRA was delisted on the 16th of November, 2023.
12 hedge funds and large institutions have $643K invested in Comera Life Sciences Holdings, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
25% less funds holding
Funds holding: 16 → 12 (-4)
32% less capital invested
Capital invested by funds: $941K → $643K (-$298K)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$64.3K |
| 2 |
State Street
Boston,
Massachusetts
|
+$43.3K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.3K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2.41K |
| 5 |
Morgan Stanley
New York
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Arena Investors
Purchase,
New York
|
-$137K |
| 2 |
BCM
Bluefin Capital Management
New York
|
-$32K |
| 3 |
VF
Virtu Financial
New York
|
-$25K |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$22K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$18K |
CMRA Hedge Fund Activity: Q4 2022 in Review
12 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Comera Life Sciences Holdings, Inc. Common Stock (CMRA) for Q4 2022, worth a combined $643K — down 32% from $941K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CMRA and 2 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Vanguard Group, opening a new position worth an estimated $64.3K. The largest seller was Arena Investors, exiting entirely with an estimated $137K sold.
- 12 institutional investors held Comera Life Sciences Holdings, Inc. Common Stock (CMRA) as of Q4 2022, down from 16 in Q3 2022.
- Funds reported $643K of Comera Life Sciences Holdings, Inc. Common Stock stock for Q4 2022, down 32% quarter-over-quarter.
- 2 funds opened new Comera Life Sciences Holdings, Inc. Common Stock positions in Q4 2022 and 6 closed out, a net change of -4 holders.
- The largest Comera Life Sciences Holdings, Inc. Common Stock buyer in Q4 2022 was Vanguard Group, an estimated $64.3K added.
- The largest Comera Life Sciences Holdings, Inc. Common Stock seller in Q4 2022 was Arena Investors, an estimated $137K sold.
Based on aggregated 13F filings for Q4 2022.